Tag Archives: Sage&#039s

Sage's postpartum depression drug is approved. Now comes the hard part

The Food and Drug Administration on Tuesday issued its first-ever approval of a postpartum depression therapy, offering a new treatment option for the roughly one in nine women who experience this kind of disorder. The question remains, however, of how accessible that option will end up being for patients. Branded as Zulresso, the therapy supplies… Read More »